Profitability Ratios
| Ratio |
Value |
| GP Margin |
56.8% |
| EBIT Margin |
-13.3% |
| EBITDA Margin |
6.6% |
| Operating Margin |
20.0% |
| Pretax Margin |
-17.3% |
| Cont. Ops Margin |
-18.5% |
| Net Margin |
-18.5% |
| Bottom Line Margin |
-18.5% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.25 |
| Quick Ratio |
1.15 |
| Solvency Ratio |
0.009 |
| Cash Ratio |
0.44 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
-12.81 |
| PEG Ratio |
0.06 |
| Forward PEG |
0.06 |
| Price/Book |
7.02 |
| Price/Sales |
2.37 |
| Price/FCF |
8.22 |
| Price/Op Cash Flow |
7.55 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.5529 |
| Debt/Equity |
3.1344 |
| Debt/Capital |
0.7581 |
| Long-Term Debt/Capital |
0.7445 |
| Financial Leverage |
5.67 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
6.23 |
| Operating Cash Flow Ratio |
0.639 |
| Operating Cash Flow/Sales |
31.4% |
| Free Cash Flow/Operating Cash Flow |
91.8% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
0.65 |
| Interest Coverage |
4.9605 |
| Short-Term Operating Cash Flow Coverage |
7.42 |
| Operating Cash Flow Coverage |
0.30 |
| Capital Expenditure Coverage |
12.17 |
| Dividend + Capital Expenditure Coverage |
2.49 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
-54.3473% |
| Dividend Yield |
4.2417% |
| Dividend Yield % |
4.2417% |
| Dividend Per Share |
2.3991 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
23.83 |
| EPS |
-4.414 |
| Debt/Share |
26.2195 |
| Cash/Share |
5.36 |
| Book Value/Share |
8.08 |
| Tangible BV/Share |
-14.29 |
| Equity/Share |
8.06 |
| Operating Cash Flow/Share |
7.494 |
| Capital Expenditure/Share |
0.616 |
| FCF/Share |
6.878 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.068 |
| Earnings Before Tax/EBIT |
-0.868 |
| Price/Fair Value |
7.02 |
| Debt/Market Cap |
0.4331 |
| Effective Tax Rate |
-6.6% |
| Enterprise Value Multiple |
49.08 |
BMY - Bristol-Myers Squibb Company